Bibliography

Found 816 results
2015
Somboonwit C, Sinnott JT, Shapshak P, Kuhn J, Sinnott JT. XMRV: Emerging human infection or false alarm in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015. pp. 561-574.
Shapshak P, Somboonwit C, Foley BT, Alraaba SF, Wills T, Sinnott JT, Kuhn J. Zika Virus. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015. pp. 477-500.
2014
Mindt MRivera, Miranda C, Arentoft A, Byrd D, Monzones J, Fuentes A, Arias F, Rentería MA, Rosario A, Morgello S. Aging and HIV/AIDS: neurocognitive implications for older HIV-positive Latina/o adults. Behavoiral Medicine [Internet]. 2014 ;40(3):116-123. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25090364
Lucas CH, Calvez M, Babu R, Brown A. Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neuroscience Letters [Internet]. 2014 ;558:97-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24215932
Vartak-Sharma N, Gelman B, Joshi C, Borgmann K, Ghorpade A. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression. J Biol Chem. 2014 ;289(28):19599-612.
Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T. Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Current HIV Research [Internet]. 2014 ;12(2):97-110. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24862332
Williams DW, Byrd D, Rubin LH, Anastos K, Morgello S, Berman JW. CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm. 2014 ;1(3):e36.
Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS [Internet]. 2014 ;28(11):1579-1591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24752083
Adiga R, Ozdemir AY, Carides A, Wasilewski M, Yen W, Chitturi P, Ellis RJ, Langford D. Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. Journal of NeuroVirology [Internet]. 2014 ;20(4):371-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24817145
Zenón F, Segarra AC, Gonzalez M, Meléndez LM. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 2014 ;9(5):703-15.
Pulliam L. Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection. Curr HIV Res. 2014 ;12(2):77-84.
Tatro ET, Soontornniyomkij B, Letendre S, Achim C. Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir. BMC Infect Dis. 2014 ;14:386.
Gutierrez J, Goldman JE, Honig L, Elkind MSV, Morgello S, Marshall RS. Determinants of cerebrovascular remodeling: Do large brain arteries accomodate stenosis?. Atherosclerosis [Internet]. 2014 ;235(2):371-379. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24929285
Dever SM, Costin BN, Xu R, El-Hage N, Balinang J, Samoshkin A, O'Brien MA, McRae M, Diatchenko L, Knapp PE, et al. Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals. AIDS. 2014 ;28(1):19-30.
Fellows RP, Byrd D, Morgello S. Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS. J Clin Exp Neuropsychol. 2014 ;36(8):806-17.
Meulendyke KA, Ubaida-Mohien C, Drewes JL, Liao Z, Gama L, Witwer KW, Graham DR, M Zink C. Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease. J Infect Dis. 2014 ;210(6):904-12.
Desplats P, Dumaop W, Cronin P, Gianella S, Woods SPaul, Letendre S, Smith DM, Masliah E, Grant I. Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS One. 2014 ;9(7):e102555.
Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Evidence of the innate antiviral and neuroprotective properties of progranulin. PLoS One. 2014 ;9(5).
Holder GE, McGary CM, Johnson EM, Zheng R, John VT, Sugimoto C, Kuroda MJ, Kim W-K. Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection. J Neuroimmune Pharmacol. 2014 ;9(5):716-26.
Thames AD, Maganpatay L, Martínez-Maza O, Singer EJ, Hinkin CH, Byrd D, Levine AJ. Genotype, CSF inflammation, and cognitive impairment among African Americans and European Americans with HIV. 2014 .
Yuan S-B, Shi Y, Chen J, Zhou X, Li G, Gelman B, Lisinicchia JG, Carlton SM, Ferguson MR, Tan A, et al. Gp120 in the pathogenesis of human immunodeficiency virus-associated pain. Ann Neurol. 2014 ;75(6):837-50.
Morgello S, Murray J, Van Der Elst S, Byrd D. HCV, but not HIV, is a risk factor for cerebral small vessel disease. Neurol Neuroimmunol Neuroinflamm. 2014 ;1(3):e27.
Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL, Gelman B, Kolson DL. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.
Kumar A, Ownby RL, Fernandez F, Valdes E, Kumar M. HIV -1 in the CNS in Post-cART era: Impact of Infection on Serotonin Status in Different Regions of Post Mortem Human Brain. In: 12th ISNV Symposium. 12th ISNV Symposium. New York: J. NeuroVirology; 2014.
Soontornniyomkij V, Umlauf A, Chung SA, Cochran ML, Soontornniyomkij B, Gouaux B, Toperoff W, Moore DJ, Masliah E, Ellis RJ, et al. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 ;28(9):1297-306.

Pages